Results 101 to 110 of about 28,900 (248)

T‐Stenting with Drug‐Eluting Stents for the Treatment of Bifurcation In‐Stent Restenosis [PDF]

, 2002
David G. Rizik, Neil C. Barman, Andre P Bouhasin, BERNARD J. VTLLEGAS   +3 more
openalex   +1 more source

Impact of Coronary Calcification on Complete Revascularization in Patients With Acute Coronary Syndrome and Multivessel Disease

Catheterization and Cardiovascular Interventions, Volume 105, Issue 7, Page 1646-1655, June 1, 2025.
ABSTRACT Background Coronary calcification is a well‐known marker of atherosclerotic plaque burden and a determinant of stent under expansion with unfavorable long‐term outcomes. Aims This sub study of the randomized BIOVASC trial aimed to compare immediate complete revascularization (ICR) and staged complete revascularization (SCR) in patients with ...
William Camilleri, Hala Kakar, Jacob J. Elscot, Eric Boersma, Nicolas M. Van Mieghem, Roberto Diletti, Joost Daemen, Elena Ntantou, Jeroen Wilschut, Rutger Jan Nuis, Wijnand K. Den Dekker   +10 more
wiley   +1 more source

A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues

Nature Communications
Drug-eluting stent implantation suppresses the excessive proliferation of smooth muscle cells to reduce in-stent restenosis. However, the efficacy of drug-eluting stents remains limited due to delayed reendothelialization, impaired intimal remodeling ...
Haoshuang Wu, Li Yang, Rifang Luo, Li Li, Tiantian Zheng, Kaiyang Huang, Yumei Qin, Xia Yang, Xingdong Zhang, Yunbing Wang   +9 more
doaj   +1 more source

Stent Fracture after Everolimus-Eluting Stent Implantation

Cardiology Research and Practice, 2011
Compared with bare-metal stents, drug-eluting stents (DES) have greatly reduced the risk of in-stent restenosis (ISR) by inhibiting neointimal growth. Nevertheless, DES are still prone to device failure, which may lead to cardiac events.
Ali S. Almasood, Xavier Freixa, Sohail Q. Khan, Peter H. Seidelin, Vladimír Džavík   +4 more
doaj   +1 more source

First drug-eluting coronary stent approved [PDF]

, 2003
Cheryl Thompson
openalex   +1 more source

Enhanced Drug Effect With Cutting Balloon Followed by Drug Coated Balloon in a Rabbit Model

Catheterization and Cardiovascular Interventions, Volume 105, Issue 7, Page 1656-1663, June 1, 2025.
ABSTRACT Background Drug‐coated balloon (DCB) are effective treatment options for patients with coronary artery disease and using of scoring or cutting balloon before the DCB usage were recommended. However, the effectiveness of lesion preparation with cutting balloons (CB) followed by DCB (CB + DCB) has not been evaluated before.
Manabu Shiozaki, Sho Torii, Yu Sato, Kazuki Aihara, Yuki Matsumoto, Norihito Nakamura, Daiki Suzuki, Ayako Yoshikawa, Yuji Ikari, Gaku Nakazawa   +9 more
wiley   +1 more source

Vascular Radiation in a Drug-Eluting Stent World [PDF]

, 2003
Paul S. Teirstein, Spencer B. King
openalex   +1 more source

Ischaemic Heart Disease Masquerading as Headache: A Case Series

Catheterization and Cardiovascular Interventions, Volume 105, Issue 7, Page 1726-1729, June 1, 2025.
ABSTRACT Headache is a rare yet clinically significant presentation of ischaemic heart disease (IHD). While chest pain is the hallmark symptom of myocardial ischaemia (MI), some patients present with atypical symptoms, such as headaches, which lead to diagnostic challenges and potential delays in treatment.
Ibrahim Antoun, Ayman Helal, Nancy Wassef, Mohsin Farooq   +3 more
wiley   +1 more source

Everolimus-eluting stents: update on current clinical studies

Medical Devices: Evidence and Research, 2011
Dominic J Allocco, Anita A Joshi, Keith D DawkinsBoston Scientific Corporation, Natick, MA, USAAbstract: Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide.
Allocco DJ, Joshi AA, Dawkins KD
doaj  

Retained Drug-eluting Stents and Recalcitrant Chronic Rhinosinusitis: A Case Report

Allergy & Rhinology, 2013
Corticosteroids are the mainstay of treatment for refractory chronic rhinosinusitis. The off-label use of steroid-eluting stents has increasingly gained popularity in functional endoscopic sinus surgery for decreasing postoperative inflammation and ...
Phayvanh P. Sjogren Ph.D., Noah P. Parker M.D., Holly C. Boyer M.D.   +2 more
doaj   +1 more source